Indivisible Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Indivisible Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$205K	Buy	+1,300	New	+$205K	0.01%	704

Other funds holding XBI

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

Annex Advisory Services Brookfield, Wisconsin $6.11B AUM 13.75% 1-Year Est. Return

MIRAE ASSET SECURITIES (USA) INC. New York $3.57B AUM 26.72% 1-Year Est. Return

Moss Adams Wealth Advisors Seattle, Washington $1.53B AUM 19.03% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Parkway Wealth Management Plano, Texas $869M AUM 25.74% 1-Year Est. Return

Weatherly Asset Management Del Mar, California $1.42B AUM 33.31% 1-Year Est. Return

L. Roy Papp & Associates Phoenix, Arizona $981M AUM 26.21% 1-Year Est. Return

Madrona Financial Services Everett, Washington $646M AUM 23.24% 1-Year Est. Return

Indivisible Partners's XBI Position: Q3 2026 in Review

Indivisible Partners opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 1,300 shares worth $205K. The stake represents 0.01% of the portfolio and ranks #704 among its holdings.

375 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Indivisible Partners held 1,300 shares of State Street SPDR S&P Biotech ETF worth $205K as of Q3 2026.
State Street SPDR S&P Biotech ETF was a new Indivisible Partners position in Q3 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Indivisible Partners's portfolio in Q3 2026, its #704 holding.
375 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Indivisible Partners's 13F filing for Q3 2026, filed 26 Oct 2026.